| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human TGF-β1 (carrier-free) |
|---|
| Description | TGF-β1 is synthesized in cells as a 390-amino acid. Furin cleaves the protein at residue 278, yielding an N-terminal cleavage product which corresponds to the latency-associated peptide (LAP), and the 25-kD C-terminal portion of the precursor constitutes the mature TGF-β1. TGF-β activators can release TGF-β from LAP. These activators include proteases that degrade LAP, thrombospondin-1, reactive oxygen species, and integrins avb6 and avb8. Mouse TGF-β converts naïve T cells into regulatory T (Treg) cells that prevent autoimmunity. Although human TGF-β1 is widely used for inducing FOXP3+ in vitro, it might not be an essential factor for human Treg differentiation. Th17 murine can be induced from naïve CD4+ T cells by the combination of TGF-β1 and IL-6 or IL-21. Nevertheless, the regulation of human Th17 differentiation is distinct. TGF-β1 seems to have dual effects on human Th17 differentiation in a dose-dependent manner. While TGF-β1 is required for the expression of RORγt, in human naive CD4+ T cells from cord blood, TGF-β1 can inhibit the function of RORγt at high doses. By using serum-free medium, it has been clarified that the optimum conditions for human Th17 differentiation areTGF-β1, IL-1β, and IL-2 in combination with IL-6, IL-21 or IL-23. |
|---|
| Size | 100 µg |
|---|
| Concentration | n/a |
|---|
| Applications | BA |
|---|
| Other Names | Transforming growth factor beta 1 |
|---|
| Gene, Accession, CAS # | Gene ID: 7040 |
|---|
| Catalog # | 580706 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human TGF-β1 (carrier-free) from BIOLEGEND |
|---|
| Product Specific References | PubMed: 22219321,23843639 |
|---|
| 产品资料 |
|
|